UY23633A1 - PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS - Google Patents

PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Info

Publication number
UY23633A1
UY23633A1 UY23633A UY23633A UY23633A1 UY 23633 A1 UY23633 A1 UY 23633A1 UY 23633 A UY23633 A UY 23633A UY 23633 A UY23633 A UY 23633A UY 23633 A1 UY23633 A1 UY 23633A1
Authority
UY
Uruguay
Prior art keywords
antigens
echinococcus granulosus
vaccines containing
protective
granulosus infection
Prior art date
Application number
UY23633A
Other languages
Spanish (es)
Inventor
Duncan Heath David
Bruce Lawrence Stephen
John Ralston Mark
Richard Maas David
William Lightowlers Marshall
Original Assignee
New Zealand Pastoral Agricultural Res Institute Limited
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Pastoral Agricultural Res Institute Limited, Univ Melbourne filed Critical New Zealand Pastoral Agricultural Res Institute Limited
Priority to UY23633A priority Critical patent/UY23633A1/en
Publication of UY23633A1 publication Critical patent/UY23633A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Este invento se refiere a polipéptidos o fragmentos peptídicos antigénicos o a variantes de ellos que son adecuados para usar en vacunas para proteger a huéspedes susceptibles de ser infectados por parásitos del género Echinococcus o Taenii, en particular de ser infectados por Echinococcus granulosus. Los antígenos son obtenidos preferentemente por expresión del DNA que los codifica en una célula huésped recombinante.This invention relates to antigenic polypeptides or peptide fragments or variants thereof that are suitable for use in vaccines to protect hosts susceptible to being infected by parasites of the genus Echinococcus or Taenii, in particular from being infected by Echinococcus granulosus. Antigens are preferably obtained by expression of the DNA encoding them in a recombinant host cell.

UY23633A 1993-08-20 1993-08-20 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS UY23633A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY23633A UY23633A1 (en) 1993-08-20 1993-08-20 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY23633A UY23633A1 (en) 1993-08-20 1993-08-20 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Publications (1)

Publication Number Publication Date
UY23633A1 true UY23633A1 (en) 1993-09-10

Family

ID=71096372

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23633A UY23633A1 (en) 1993-08-20 1993-08-20 PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

Country Status (1)

Country Link
UY (1) UY23633A1 (en)

Similar Documents

Publication Publication Date Title
AR003425A1 (en) RECOMBINANT MAPACHE POXVIRUS, VACCINE FOR USE IN CATS AND USE OF POXVIRUS TO PREPARE A VACCINE USEFUL TO AVOID OR DECREASE THE DISEASE CAUSED BY THE FELINE IMMUNODEFICIENCY VIRUS (IVF)
DK0835133T3 (en) Recombinant smallpox virus rabies and combination preparations and their uses
AU6564696A (en) Recombinant attenuated ALVAC canarypox expression vectors containing heterologous DNA segments encoding lentiviral gene products
DE69233158D1 (en) GENETICALLY MANUFACTURED STRAIN FOR VACCINES
CY1106635T1 (en) N-FORMYL METHIONYL-PEPTIDE CONTAINING IMMUNOPRODUCT FOR VACCINES
MX9204685A (en) DNA SEQUENCE CODING AN EXTERNAL SURFACE PROTEIN (OSPA) OR DERIVED FROM THE SAME VACCINE COMPOSITION QE INCLUDES SUCH PROTEIN.
ES2070866T3 (en) RECOMBINANT VACCINES AGAINST COCCIDIOSIS.
DE69829668D1 (en) PREPARATION AND USE OF RECOMBINANT INFLUENZA A VIRUS M2 CONSTRUCTIONS AND IMPORTS
DK0996717T3 (en) Immune protective influenza antigen and its use for vaccination
DK0596979T3 (en) Plant virus recombinant nucleic acids
ATE328068T1 (en) PAPILLOMAVIRUS VACCINE
ES2170075T3 (en) MULTIVALLY RECOMBINANT PROTEIN M VACCINE.
CO4480039A1 (en) RECOMBINANT FELINE IMMUNODEFICIENCY VACCINES PRODUCED IN BACULOVIRUSES AND THEIR USE AGAINST INFECTION WITH FELINE IMMUNODEFICIENCY VIRUSES
MXPA06013388A (en) Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine.
AR248045A1 (en) Recombinant avipox virus
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
DK0437604T3 (en) Recombinant poxvirus and streptococcal M protein vaccine
ES2127294T3 (en) VACCINES OF ANTI-FELINE IMMUNODEFICIENCY VIRUSES (IVF).
EP0319570A4 (en) Recombinant human cytomegalovirus containing foreign gene and use thereof
WO2005046621A3 (en) Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ATE147782T1 (en) PRIMATE LENTIVIRUS VACCINES
NO922728L (en) Vaccine against COCCIDIOSIS
UY23633A1 (en) PROTECTIVE ANTIGENS AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
DK0831899T3 (en) Recombinant smallpox virus calicivirus preparations and applications